QLY Biotech Group Corp.
LQLY
$1.00
-$0.06-5.66%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.60K | 9.20K | 4.80K | 3.30K | 1.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.60K | 9.20K | 4.80K | 3.30K | 1.80K |
| Operating Income | -11.60K | -9.20K | -4.80K | -3.30K | -1.80K |
| Income Before Tax | -11.60K | -9.20K | -4.80K | -3.30K | -1.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.60K | -9.20K | -4.80K | -3.30K | -1.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.60K | -9.20K | -4.80K | -3.30K | -1.80K |
| EBIT | -11.60K | -9.20K | -4.80K | -3.30K | -1.80K |
| EBITDA | -11.60K | -9.10K | -4.80K | -3.30K | -1.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 3.90M | 3.90M | 3.90M | 3.90M | 3.90M |
| Average Diluted Shares Outstanding | 3.90M | 3.90M | 3.90M | 3.90M | 3.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |